NYSE:MDTMedical Equipment
Medtronic (MDT) Launches Global Study On Novel Heart Failure Treatment
Medtronic (MDT) has recently initiated the ELEVATE-HFpEF study focusing on heart failure treatment, which, alongside other product developments and strategic initiatives, coincides with a positive quarter-end price movement of 9%. This period saw advancements such as the launch of the Hugo™ robotic-assisted surgery system and FDA approval for the MiniMed™ 780G system, which likely supported investor sentiment. The broader market trend was upward, with indexes reaching record highs amid...